Sculptor Capital’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Sculptor Capital’s Portfolio BSX.PRA Stock Details BSX.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-61,765	Closed	-$7.48M	–	576
2023 Q1	$7.48M	Hold	61,765	–	–	0.17%	100
2022 Q4	$7.09M	Buy	+61,765	New	+$6.81M	0.12%	193
2020 Q3	–	Sell	-75,165	Closed	-$7.88M	–	386
2020 Q2	$7.88M	Buy	+75,165	New	+$8.05M	0.07%	109

Other funds holding BSX.PRA

LTI

Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return

Sculptor Capital's BSX.PRA Position: Q2 2023 in Review

Sculptor Capital sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 61,765 shares — an estimated $7.48M sold.

Sculptor Capital first reported a position in BSX.PRA in Q2 2020 and held it in 3 quarters. The position peaked at $7.88M in Q2 2020. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

Sculptor Capital reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
Sculptor Capital sold 61,765 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $7.48M.
Sculptor Capital first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q2 2020 and held it in 3 quarters.
Sculptor Capital's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $7.88M in Q2 2020.
1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Sculptor Capital's 13F filing for Q2 2023, filed 14 Aug 2023.